CRISPR-Cas systems are used to provide adaptive immunity against mobile genetic elements in bacteria and archaea. Among these, type IV-A1 CRISPR-Cas systems are distinguished from other CRISPR types by the absence of canonical DNA or RNA nuclease activity. Instead, target DNA is unwound through the recruitment of a DinG helicase by these multisubunit complexes, resulting in transcriptional interference rather than cleavage and in this way preventing the infection \(^{[1][2]}\).
Structural and biochemical studies have primarily been conducted on canonical type IV-A1 systems, in which a Cas8 homolog is employed in combination with Cas5 to mediate protospacer adjacent motif (PAM) recognition \(^{[3][4]}\). In contrast, a recently reclassified non-canonical type IV-A1 system – formerly designated type IV-A2 – has remained largely unexplored \(^{[1]}\). These systems were long thought to lack a Cas8 homolog, suggesting that an alternative mechanism of target recognition was used \(^{[5]}\). However, it has been shown that non-canonical type IV-A1 systems consistently co-occur with a small, conserved, cas8-like gene located adjacent to the cas operon and transcribed in the opposite orientation. Understanding of the function of the protein encoded by this gene may reveal a previously unrecognized component of type IV-A1 interference and expand current understanding of CRISPR-Cas systems diversity.
Here, initial insights into the structure and mechanism of a representative non-canonical type IV-A1 CRISPR-Cas system are presented.